Low Testosterone in Your 30s
Understanding Normal vs. Low Testosterone Levels in Your 30sTestosterone levels naturally begin declining around age 30, typically dropping 1-2% annually. However, this [...]
Read MoreLiquid Biopsies: A Less Invasive Alternative for Cancer Diagnosis
Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on June 12th, 2024. Updated on April 30th, 2026
Key Takeaways
Blood-based testing detects circulating tumor DNA (ctDNA) and cancer cells that tumors shed into the bloodstream, requiring only a simple blood draw versus surgical tissue removal.
Detection accuracy reaches 85-90% for advanced stage cancers but drops to 40-50% for early-stage tumors, making timing and cancer progression critical factors.
Results are typically available within 7-14 days compared to 2-4 weeks for traditional tissue biopsies, enabling faster treatment decisions.
False negatives occur in 15-30% of cases since not all cancers release detectable DNA into blood, particularly small or localized tumors.
Monitoring treatment response shows changes in ctDNA levels within 2-4 weeks, often before imaging can detect tumor shrinkage or growth.
When it comes to diagnosing cancer, a tissue biopsy is the standard test. However, a less invasive alternative called a liquid biopsy is gaining attention for its potential to provide a diagnosis when a traditional biopsy may not be possible or practical.
What is a Liquid Biopsy?
A liquid biopsy uses a person's blood to look for signs of cancer. The test aims to detect circulating tumor cells or mutated DNA that a tumor has shed into the bloodstream. By analyzing these components, doctors can potentially:
Predict and monitor responses to cancer treatments
Detect cancer early, before it has had a chance to spread
Advantages of Liquid Biopsies
Compared to traditional tissue biopsies, liquid biopsies offer several advantages:
Less invasive and painful, as they only require a blood sample
Can find cancer-specific DNA in more than 85% of patients with advanced cancers
Can help identify cancer that tissue biopsies may miss
Can determine when cancer treatments are no longer effective by detecting genetic mutations that cause resistance to therapy
The Future Role of Liquid Biopsies
While liquid biopsies show promise, their impact on overall cancer survival is not yet known. Currently, liquid biopsies are used alongside tissue biopsies to confirm a diagnosis and guide treatment. This two-sided approach is necessary because, although liquid biopsies have a good track record for accuracy, they can still miss cancers in some people or suggest cancer is present when it isn't.
As research continues, liquid biopsies may play an increasingly important role in cancer care. Their less invasive nature and ability to detect cancer early could ultimately lead to better outcomes for patients.
Additional Resources:
Liquid Biopsy: Using DNA in Blood to Detect, Track, and Treat Cancer - National Cancer Institute
Liquid biopsy - Mayo Clinic
Liquid Biopsies: Past, Present, and Future - American Cancer Society
The Bottom Line
This blood-based technology offers a faster, less invasive way to detect and monitor cancer, though it works best as a complement to traditional biopsies rather than a complete replacement. The accuracy varies significantly based on cancer stage and type, making proper interpretation crucial. If you're concerned about cancer symptoms or need guidance on diagnostic testing options, Doctronic can help connect you with appropriate screening.
Related Articles
Can You Take Claritin (Loratadine) While Pregnant?
Safety Profile of Loratadine During PregnancyLoratadine, commonly known by the brand name Claritin, holds an FDA pregnancy category B classification, which provides important [...]
Read MoreHow Much Does Claritin (Loratadine) Cost Without Insurance?
Current Loratadine Pricing Across Major RetailersWhen shopping for loratadine without insurance, understanding pricing differences across major retailers can save you [...]
Read More
